Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21348413rdf:typepubmed:Citationlld:pubmed
pubmed-article:21348413lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:21348413lifeskim:mentionsumls-concept:C0311392lld:lifeskim
pubmed-article:21348413lifeskim:mentionsumls-concept:C0153687lld:lifeskim
pubmed-article:21348413lifeskim:mentionsumls-concept:C0333348lld:lifeskim
pubmed-article:21348413lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:21348413lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:21348413lifeskim:mentionsumls-concept:C0007320lld:lifeskim
pubmed-article:21348413pubmed:issue6lld:pubmed
pubmed-article:21348413pubmed:dateCreated2011-2-25lld:pubmed
pubmed-article:21348413pubmed:abstractTextSkin metastases are present in 1-9% of cancer patients. In rare cases, skin metastases can manifest as lesions with signs of inflammation and are diagnosed as inflammatory cutaneous metastases (ICM). ICM in lung cancer are extremely rare and often misdiagnosed.lld:pubmed
pubmed-article:21348413pubmed:languageenglld:pubmed
pubmed-article:21348413pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21348413pubmed:citationSubsetIMlld:pubmed
pubmed-article:21348413pubmed:statusMEDLINElld:pubmed
pubmed-article:21348413pubmed:issn0862-495Xlld:pubmed
pubmed-article:21348413pubmed:authorpubmed-author:MardiakJJlld:pubmed
pubmed-article:21348413pubmed:authorpubmed-author:MartanovicPPlld:pubmed
pubmed-article:21348413pubmed:authorpubmed-author:MegoMMlld:pubmed
pubmed-article:21348413pubmed:authorpubmed-author:Sycova-MilaZZlld:pubmed
pubmed-article:21348413pubmed:authorpubmed-author:ObertovaJJlld:pubmed
pubmed-article:21348413pubmed:authorpubmed-author:LiskovaSSlld:pubmed
pubmed-article:21348413pubmed:issnTypePrintlld:pubmed
pubmed-article:21348413pubmed:volume23lld:pubmed
pubmed-article:21348413pubmed:ownerNLMlld:pubmed
pubmed-article:21348413pubmed:authorsCompleteYlld:pubmed
pubmed-article:21348413pubmed:pagination449-51lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:meshHeadingpubmed-meshheading:21348413...lld:pubmed
pubmed-article:21348413pubmed:year2010lld:pubmed
pubmed-article:21348413pubmed:articleTitleInflammatory skin metastasis as a first sign of progression of lung cancer--a case report.lld:pubmed
pubmed-article:21348413pubmed:affiliationDepartment of Medical Oncology School of Medicine, Comenius University, Bratislava, Slovakia. misomego@gmail.comlld:pubmed
pubmed-article:21348413pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21348413pubmed:publicationTypeCase Reportslld:pubmed